Jump to content
  • --==>> JOIN A RANDOM TOPIC HERE
  • Active Topics Today

  • Activity Stream

    1. 20

      What's The Difference Between Mortgages and Reverse Mortgages?

    2. 3

      How To Be A Vegetarian

    3. 34

      What Songs Are You Listening To In 2021?

  • Recent Achievements

    • TITAN earned a badge
      Reacting Well
    • News earned a badge
      First Post
    • News earned a badge
      Week One Done
    • News earned a badge
      One Month Later
    • Chorus earned a badge
      Collaborator
  • Popular Contributors

    Nobody has received reputation this week.

What Covid Vaccine Did You Get?


Recommended Posts

  • 2 weeks later...

WHO approves Sinovac COVID Shot

The World Health Organization (WHO) said on Tuesday it has approved a COVID-19 vaccine made by Sinovac Biotech (SVA.O) for emergency use listing, paving the way for a second Chinese shot to be used in poor countries.

A WHO emergency listing is a signal to national regulators of a product’s safety and efficacy and will allow the Sinovac shot to be included in COVAX, the global programme providing vaccines mainly for poor countries, which faces major supply problems due to curbs on Indian exports.

The WHO's independent panel of experts said in a statement it recommended Sinovac's vaccine for adults over 18. There was no upper age limit as data suggested it is likely to have a protective effect in older people.

The WHO's technical advisory group, which began meeting on May 5, made the decision after reviewing the latest clinical data on the Sinovac vaccine's safety and efficacy as well as the company's manufacturing practices.

WHO Director-General Tedros Adhanom Ghebreyesus welcomed the move, calling the vaccine safe and effective and noting its easy storage requirements make it suitable for low-income countries.

"It's now crucial to get these lifesaving tools to the people that need them quickly," he told a briefing.

Branded CoronaVac in some regions, it is the eighth vaccine to win such a WHO listing to combat COVID-19 and the second developed by a Chinese company, after the May 7 approval of a shot developed by state-backed Sinopharm.

While a third Chinese vaccine, produced by CanSino Biologics (6185.HK), has submitted clinical trial data, no WHO review has been scheduled.

Sinovac said that it had supplied more than 600 million doses of its vaccine at home and abroad as of end-May and over 430 million doses have been administered.

Link to comment
Share on other sites

  • 4 weeks later...

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

 Share

×
×
  • Create New...